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Abstract 
 
The aim of this study was to determine whether the apparent reduction in cell 
number and -SMA expression of porcine mitral valvular interstitial cells plated on 
substrates of varying stiffness was due to apoptosis or dedifferentiation.  This decrease 
was determined to be a result of apoptosis as indicated by caspase levels comparable to 
the positive control.  A more thorough investigation into cellular communication and 
signaling will be invaluable to the development of next generation valve replacements.   
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Introduction 
 
The Circulatory System 
 
 Within three weeks of conception the heart of the developing embryo begins to 
beat.  The heart of the embryo develops so early because it is part of a crucial transport 
system of the body, the circulatory system.  The human embryo develops a circulatory 
system to interact with the maternal circulatory system to ensure food supply during 
development.  The circulatory system continues to be imperative throughout life to 
transport materials to the cells of the body which are necessary for survival.  The 
circulatory system is comprised of three parts:  the heart, blood vessels, and the blood.   
 The main organ of the circulatory system, the heart, is located in the thoracic 
cavity between the sternum and the vertebrae.  It is a hollow, yet muscular organ about 
the size of the fist.  The main responsibility of the heart is to pump blood to and from the 
tissues of the body.  Even though the heart is a single organ, the right and left sides of the 
heart function as two separate pumps.  The heart has four chambers as seen in Figure 1.  
The upper chambers include the atria and the lower chambers are comprised of the 
Figure 1.  The heart’s chambers (Hartzog 2005) 
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ventricles.  The atria are responsible for receiving blood from circulation and transferring 
it to the lower chambers.  The ventricles function to pump blood out of the heart.   
 
Heart Valves 
 
Blood flows through the heart in one direction--from the veins to the atria to the 
ventricles and to arteries.  The one-way heart valves ensure that blood circulates in this 
direction every time through the heart.   Two of the heart valves are positioned between 
the atrium and ventricle on the right and left sides and are called the right and left 
atrioventricular (AV) valves.  The right AV valve is called a tricuspid valve because it 
consists of three cusps and the left AV valve is named a bicuspid valve because it 
consists of two cusps.  Another name for the left AV valve is the mitral valve.   
Anatomically, the mitral valve is located on the left side of the heart between the 
left atrium and the left ventricle as seen in Figure 1.  The mitral valve has two leaflets 
called the anteromedial leaflet and the posterolateral leaflet which guard the opening.  
The opening is surrounded by the annulus, a tough fibrous ring.  These two leaflets are 
prevented from prolapsing into the left atrium by the fibrous cords called chordae 
tendinae shown in Figure 2.  
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Figure 2.  A close-up of the mitral valve (Focosi 2005) 
 
  The heart valves are made of connective tissue and therefore open and close 
passively.  Heart valves open and close due to changes in pressure.  The AV valves open 
during ventricular diastole when the pressure in the atria is greater than the pressure in 
the ventricles and close during ventricular systole when pressure in the ventricles is 
greater than pressure in the atria.  Chordae tendinae function to prevent the valves from 
being opened in the opposite direction into the atria due to high pressure.  Semilunar 
valves, on the other hand, open during ventricular systole when the pressure in the 
ventricles is greater than the pressure in the arteries and close during ventricular diastole 
when the pressure in the pulmonary trunk and aorta is greater than the pressure in the 
ventricles.   
In addition to the external features of the valves, the AV valves are composed of 
several distinct layers of tissue:  spongiosa, fibrosa, ventricularis, and the atrialis layer 
(Mulhollan and Gotlieb 1996).  The spongiosa is composed of loose connective tissue, 
proteoglycans, elastin and collagen.  The fibrosa layer contains several sheets of collagen 
bundles.  The thinnest of the layers, the ventricularis, is comprised primarily of elastic 
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fibers.  Lastly, the atrialis includes elastic fibers, smooth muscle cells, and valvular 
interstitial cells. 
 
Heart Valve Disease 
 
 Mitral valve disease is one of many common heart problems that affect the 
population today.  Mitral valve disease does not just affect the sick and elderly, it can 
affect anyone.  Mitral valve disease can eventually lead to more serious problems such as 
heart failure and other serious complications.  The most common mitral valve disorders 
include prolapse, regurgitation and stenosis. 
 Mitral valve prolapse is a disorder of the valve leaflets.  It is more common in 
females, those with low body weight and low systolic blood pressure (Hayes 1997).  The 
valve leaflets do not close properly because they are enlarged which cause them to 
prolapse into the left atrium.  The main cause of this enlargement is an abnormal 
proliferation of the connective tissue in the valve.  When the mitral valve leaflets do not 
close completely, regurgitation occurs.   Regurgitation of the mitral valve allows blood 
from the left ventricle to go back into the left atrium during systole.  This regurgitation 
increases the left atrial volume and pressure which can cause a progression of 
abnormalities. 
Other less common causes of mitral valve prolapse include dysfunctional or 
ruptured chordae tendineae, papillary muscle or annulus (Horsham et al 1999).  In these 
cases, other diseases such as rheumatic fever or myocardial infarction are the primary 
causes of dysfunction.  The most common symptoms include palpitations and chest 
discomfort.   
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 In mitral stenosis the orifice of the mitral valve becomes narrowed which 
obstructs blood flow from the left ventricle during diastole. Rheumatic fever remains the 
most common cause of mitral stenosis even though it is not that common in the United 
States (Hayes 1997).  The signs and symptoms of mitral stenosis may not develop until 
years later.  In the elderly population, mitral stenosis is caused by degenerative 
calcification of the valve annulus and leaflets.  Rare but possible causes of mitral stenosis 
also include systemic lupus and rheumatoid arthritis. 
In many cases of mitral valve disease, heart valve replacement has been an option.  
Heart valve replacement is becoming increasingly common in the United States with 
approximately 50,000 aortic replacements alone in the US and over 225,000 worldwide 
(Associated Press 2006). Valve surgery is quite effective in the fact that it alters the 
course of valvular disease for a period of time.  However, there are several potential 
problems of valve replacement including thromboembolism, infections, immunological 
reactions, tissue deterioration, and the need for lifelong anticoagulation.  Several of these 
shortcomings could be eliminated if we were to create a tissue engineered valve 
substitute.   
 Heart failure will become a challenge as life expectancy continues to rise.  In 
order to address the issues of heart failure and other conditions such as mitral valve 
disease, the anatomy of the valve, the maintenance of these structures and their 
importance in overall function must be thoroughly understood. 
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Present Day Treatment for Valve Dysfunction 
 
            Numerous models of heart valve replacements have been designed since the 
1960s.  Their reliability has been investigated and several improvements have been made 
in the past four decades (Schoen and Levy 1999).  When heart valve substitutes are made, 
several desirable characteristics must be taken into consideration to ensure mechanical 
dependability and patient satisfaction.  The substitute must be:  non-obstructive, and 
ensure prompt and complete closure.  It must be infection resistant, non-thrombogenic, 
durable for extended intervals, chemically inert and non hemolytic.  In addition it must be 
able to be easily and permanently inserted into the appropriate site, promote appropriate 
post surgical healing and function in a noise free manner.  Current day valve 
replacements consist of prosthetic valves that are either manufactured of non biological 
materials or tissue valves that are made with at least a percentage of either human or 
animal tissue (Schoen and Levy 1999). 
 There are several advantages to having heart valve replacements, after all, one 
needs a valve for a properly functioning heart and subsequently a healthy circulatory 
system.   Sometimes substitute heart valve implantation is necessary for survival.  Thus 
one is more often than not willing to accept some of the disadvantages that may arise post 
operation.  However there are many complications associated with heart valve 
replacement.  Prosthesis related problems usually arise within 10 years leading to a 
further operations or even death in 50-60% of patients with substitute valves (Schoen and 
Levy 1999).   Some of the most common complications that may arise include:  thrombo- 
embolism, thrombosis, anticoagulation-related hemorrhages, prosthetic valve 
endocarditis, and structural and non structural dysfunction.   
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Potential Treatments for Valve Dysfunction 
 
           Since an ideal valve replacement model has not yet been achieved, there has been 
extensive research in the development of substitute heart valves particularly tissue 
engineered valves.  Tissue engineering is a technique that allows an anatomically 
appropriate construct containing cells seeded on a scaffold to be fabricated in vitro in a 
bioreactor and then implanted into a patient.   Thus far there have been attempts to use 
tissue engineering for heart valves in animals such as lambs (Schoen and Levy 1999).  
These recent efforts have shown great potential, however, the mechanisms of valvular 
morphogenesis, especially during embryological development, are extremely complex 
and not fully understood, limiting the ability of tissue engineers to mimic this process in 
vitro.   
 
Valve Cells 
 It is important to look at the mitral valve on a cellular level because insufficient 
valve function can result from a disorder of normal cell function.  Four types of cells are 
present in or around the valve including endocardial, cardiac muscle, smooth muscle, and 
cardiac valvular interstitial cells.  The surface of the valve is covered with endocardial 
cells.  The base of the valve has an extensive amount of cardiac muscle cells which are 
also known as cardiomyocytes.  Smooth muscle cells are found in arterioles and venules 
surrounding the valve.  Lastly, valvular interstitial cells form a complex cellular 
framework spanning the entire valve. 
Because of their complexity, and their involvement in the process of valve 
pathogenesis, the valvular interstitial cells are of most importance to this study.  
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Knowledge of cardiac valvular interstitial cells contractile, secretory, and proliferative 
functions is imperative to understanding how these cells respond to valvular injury and 
essentially how they repair themselves.   
   
VIC differentiation  
Rabkin-Aikawa et al. (2004) identified two distinct phenotypes of valvular 
interstitial cells: a normal or quiescent fibroblast-like cell type characterized by 
expression of vimentin.  The other type expressed - smooth muscle actin (SMA) and has 
myofibroblast-like qualities.  This second, activated type is found in developing or 
injured valve tissue which is suggestive of a role in extracellular matrix remodeling.  
After a damaged valve has undergone remodeling, the myofibroblast-like cell is proposed 
to revert back to the quiescent fibroblast-like phenotype (Rabkin-Aikawa et al 2004).  
This plasticity is likely to be highly regulated, although little is known about the 
mechanism.   
 
Stiffness/Mechanical Properties 
 
Mechanical stress on the normal fibroblast-like VICs induces changes that can 
lead to activation marked by -SMA expression and matrix remodeling as a consequence 
of the activation (Tomasek et al.  2002).  Cultured VICs plated on standard plastic flasks 
can not be expected to exhibit the same morphological features as cells in vivo due to the 
drastic change in surrounding, especially the surface to which they are attached.  To 
provide a more in vivo-like setting in an in vitro environment, polyacrylamide substrates 
have been developed by Wang et al. (1998) to mimic mechanical properties of in vitro 
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substrate.  A benefit to using polyacrylamide is the ability to prepare substrates of 
varying stiffness by changing the ratio of bis-acrylamide to acrylamide thus allowing 
examination of the effects of substrate stiffness on cell structure and function.  Adding a 
coating of fibronectin enhances the model in that the cells may interact directly with the 
surface protein as is the case in vivo.  This allows in vitro manipulation to more closely 
mimic pathological or physiological situations.   
The Model 
 A model was created by Heather Hinds as shown in Figure 3 to describe the 
relationship between differentiation and dedifferentiation of porcine mitral valvular 
interstitial cells in vitro.  When VICs are activated or differentiated from fibroblast to 
myofibroblast-like cells, an increase in alpha smooth muscle actin expression occurs.  
This occurs due to an increase in substrate stiffness and/or transforming growth factor-  
(TGF- 1) levels.  In this model, dedifferentiation which is characterized by a decrease 
in alpha smooth muscle actin expression, is a result of decreased substrate stiffness and a 
decrease in TGF-- 1 levels (Hinds 2006).  Studies carried out by Hinds showed a 
decrease in -SMA expression in valvular interstitial cells that were initially plated on 
plastic and then on two substrates of various stiffness, 7kPa and 75 kPa.  The 7kPa 
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Figure 3.  Model for VIC differentiation and dedifferentiation (Hinds 2006) 
 
__  
 
 
substrate was used to mimic a normal healthy valve whereas the 75kPa substrate was 
used to mimic a stiff pathological heart valve.  According to the data obtained from 
Hinds, -SMA expression changed from an average of 80%  to  50%  when plated on the 
75 kPa substrates and from 80% on plastic to 45%  when plated on the 7 kPa substrates.   
Although the number of cells seeded on each substrate was initially the same it appeared 
as though fewer cells were surviving.  Our results will determine if the reason for this 
decrease was actually dedifferentiation as concluded by Hinds or apoptosis of the 
differentiated cells.   
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Materials and Methods 
 
MITRAL VALVULAR INTERSTITIAL CELL ISOLATION 
Porcine hearts were obtained from Blood Farm in Groton, MA.  Within four hours 
postmortem the heart valves were excised.  Two incisions were made in the heart, the 
first adjacent to the coronary artery and the second perpendicular to the first incision.  
The heart was opened and the distal leaflet of the mitral valve was trimmed 
approximately 5 mm from the myocardium.  The dissected portions of the mitral valve 
were placed in a beaker containing phosphate-buffered saline (PBS 150mM sodium 
chloride and 10mM sodium phosphate pH 7.4).   Both surfaces of the leaflet pieces were 
firmly scraped with a sterile cell scraper to remove endocardial cells and then rinsed in 
sterile PBS.  Leaflets were minced to 0.5cm2 pieces and digested on a rocking platform 
for 3 hours in 3 mL digestion media containing 600U/ml collagenase, 1X 
antibiotic/antimycotic (Sigma) in Dulbeccos Modified Eagles Medium (DMEM) 
(Cambrex).  Undigested tissue was removed by filtering though a nylon mesh.  Medium 
(see CELL CULTURE MEDIUM AND CONDITIONS) was added to the filtrate and 
centrifuged for 5 minutes at 1500G.  The supernatant was aspirated off and cells were re-
suspended in fresh media.  Media was changed every 3 days.  Cells were plated at 1 x 105  
cells/100mm dish and passaged once a week.   
 
CELL CULTURE MEDIUM AND CONDITIONS 
Medium consisted of (DMEM) supplemented with 2mM L-glutamine, 10% heat 
inactivated fetal bovine serum, and 1X antibiotic/antimycotic solution (Sigma).  Cells 
were cultured at 37°C in 5% CO2 and 95% air. 
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SUBSTRATE PREPARATION 
  Polyacrylamide preparation and subsequent fibronectin treatment of the substrate 
surface were all completed according to the Wang et al (1998) protocol.  The following 
modifications were made to this protocol: 51mm x 75mm glass slides were activated to 
promote adhesion of polyacrylamide to the glass surface (Electron Microscopy Science) 
and 45mm round cover slips were used to spread polyacrylamide on the glass slide 
surface.  Polyacylamide substrates were prepared by varying the ratio of acrylamide and 
bis-acrylamide to a desired stiffness of 7 kPa and 75 kPa. The final ratio of acrylamide to 
bis-acrylamide for the 7 kPa construct was 5%/0.025% and for the 75 kPa construct, 
8%/0/8% (Engler, Griffin et al. 2004).  To achieve a desired thickness of 75µm, 84µl of 
the polyacrylamide solution was placed on the activated glass slide and covered with a 
45mm #1 round cover slip.  Following polymerization of the polyacrylamide, substrates 
were rinsed in 50mM HEPES buffer pH 8.5, and the #1 cover slip was removed to expose 
the polyacrylamide surface.  Fibronectin coating of the polyacrylamide substrate was then 
completed according to the Wang et al (1998) protocol.  Substrates were UV sterilized 
for 15 minutes in a sterile hood and placed in a sterile 150mm culture dish (Corning). 
 The substrates were equilibrated overnight at 37°C in 20ml of the appropriate culture 
media and checked for contamination. 
 
IMMUNOFLUORESCENCE 
Mitral vavlular interstitial cells grown on plastic and 7 kPa and 75 kPa substrates 
were fixed and permeabilized with one drop of 10X fixation permeabilization buffer (BD 
Biosciences).  Cells were stained for alpha smooth muscle actin using a monoclonal 
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antibody.  FITC conjugated anti-alpha smooth actin (Sigma) was diluted 1:1000 in 
permeabilization and wash buffer (BD Biosciences) and incubated for one hour at 4°C.   
Substrates were washed overnight in 0.1% Tween-20 in phosphate-buffered saline to 
reduce background fluorescence due to residual antibody remaining within the 
polyacrylamide surface.  The cells were then incubated with Hoescht 33342 (Molecular 
Probes) at a dilution of 1:2000 in reagent grade de-ionized H2O for 5 minutes at room 
temperature.  After the nuclear stain, the substrates were washed three times in 0.1% 
tween-20 in PBS and then prepared for imaging.    
 
CASPASE ASSAY 
The Caspase-8 Assay protocol (Biovision) was followed.  SHSY-neuronal 
cells were plated at a concentration of 3 x 105  to be used as a positive control.  They were 
incubated with 20µM Yankner peptide which induces apoptosis in neuronal cell cultures 
(Yanker 1990).  Normal, healthy valvular interstitial cells grown on plastic were used as a 
negative control.  Three million cells were removed from 7 kPa and 75 kPa substrates 
trypsin digestion.  The caspase assay was performed in triplicate in a 96-well plate.  
Reaction buffer containing 10 mM DTT was added to each sample.  5µl of the 1mM 
IETD-AFC substrate was added to each sample and incubated at 37°C for 1-2 hours.  
Samples were read in a spectrophotometer at 405nm and relative caspase activity was 
determined by comparison with the negative and positive controls.   
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Results 
Validating the Model System – Alpha Smooth Muscle Actin Expression and Substrate 
Stiffness 
As an indicator of valvular interstitial cell differentiation to a myofibroblast 
phenotype, expression of alpha smooth muscle actin was examined by staining VICs with 
FITC conjugated anti-alpha smooth muscle actin.  DAPI staining allowed concurrent 
visualization of nuclei.  There was a greater degree of alpha smooth muscle actin 
expression in 75 kPa substrates than in 7 kPa.  This result is consistent with previous data 
collected by Hinds (2006) and validates the model for VIC differentiation and 
dedifferentiation by showing a decrease in -SMA expression after replating, especially 
on the 7 kPa substrates.   
 
Figure 4.  -SMA  expression in VICs grown on 75 kPa substrate 
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Figure 5.  -SMA  expression in VICs grown on 7 kPa substrate 
      
 
VICs grown for 96 hours on plastic show significant -SMA expression (Hinds, 
2006), while cells transferred to substrates of 7 kPa and 75 kPa for an additional 96 hours 
showed a relative decrease in -SMA  expression.  The relative intensity of -SMA 
staining was greater in cells grown on the 75 kPa substrates (Figure 4) than those grown 
on the 7 kPa (Figure 5).  Thus -SMA expression appears to increase with increasing 
substrate stiffness.   
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Assessing Levels of Apoptosis by Caspase Activity 
Dedifferentiation may offer an explanation for decreased -SMA  expression in 
VICs plated on substrates of decreasing stiffness.  However, it is also possible that the 
differentiated cells may be dying off and new less differentiated cells are repopulating the 
substrates.  An assay to determine expression levels of caspases was performed in order 
to determine whether the VICs were demonstrating increased levels of apoptosis.  As 
shown by the caspase assay, cells grown on both the 7 and 75 kPa substrates expressed 
caspase levels comparable to those of the positive control with cells grown on 7 kPa 
showing slightly more activity than those grown on the 75 kPa substrate.  Figure 6 
displays the results from the assay, which was performed on two separate cell 
preparations. 
 
 VICs Apoptotic control 
 7 kPa 75 kPa Plastic SHSY cells 
Run 1 0.158 0.156 - 0.156 
Run 2 0.179 0.134 0.104 - 
Averages 0.169 0.145 0.104 0.156 
Figure 6. The relative caspase activities of VICs plated on three substrates: 7 kPa, 75 kPa and plastic. 
The numbers represent absorbance at the 405 nm wavelength.  Increasing absorbance corresponds 
to increasing levels of caspase activity.  Neuronal SHSY cells treated with 20 µM  Yankner peptide 
served as a positive control for apoptosis. 
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Discussion 
 
 As demonstrated in this paper, as well as by Heather Hinds, levels of alpha 
smooth muscle actin expression were highest in cells plated on plastic suggesting that 
nearly all the cells were differentiated myofibroblasts.  Micrographs taken showed that 
after plating VICs on plastic for 72 hours, -SMA expression was high.  When these fully 
differentiated cells were then plated on softer substrates (7 and 75 kPa), expression of -
SMA per cell appears reduced relative to those on plastic.  Additionally, although the 
numbers of cells initially plated on the constructs was consistent, over time those cultured 
on the 7 and 75 kPa substrates had fewer cells than expected.  The combination of fewer 
cells and an apparent reduction of expression in -SMA provided us with two possible 
hypotheses.  First, when grown on a softer substrate, cells show a reduction in -SMA 
expression, suggesting they may be reverting toward a less differentiated state, or 
dedifferentiating.  The other possibility is that, since fewer cells were viable, cells 
expressing -SMA had undergone apoptosis and the apparent reversal of expression is 
the result of proliferation by a small subset of the original cells which did not express -
SMA, and remained less or un-differentiated on the 7 and 75 kPa substrates. 
 To test whether VICs plated on the 7 kPa and 75 kPa substrates were undergoing 
increased apoptosis, as opposed to dedifferentiation, a caspase assay was performed to 
examine if apoptosis was the cause of the apparent reduction in cell number and -SMA 
expression.  Our initial results indicated that compared to a positive control of cells 
actively undergoing apoptosis, the level of caspase activity in mitral valvular interstitial 
cells plated on the 7 and 75 kPa substrates was high, even exceeding the caspase activity 
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of the positive control.  This result was confirmed in a second experiment where, again, 
the levels of caspase activity were greater in the 7 kPa and 75 kPa samples of mitral VICs 
than in the positive control.  Thus it appears that instead of dedifferentiating, old cells 
which expressed -SMA are dying off and new, undifferentiated cells are taking their 
place.  Detection of caspases does not rule out dedifferentiation, though it does suggest 
strongly that the decrease in -SMA  expression is due at least in part to apoptosis of old 
cells and the formation of new, quiescent cells.  If substrate stiffness was a factor in 
caspase activity, the two different stiffnesses should show different readings.  Based on 
the hypothesis that the 7 kPA substrate induces VICs to dedifferentiate, a higher degree 
of apoptosis for cells grown on a stiffer substrate would be expected than on the 75 kPa 
substrate.   
If changes in the stiffness of the microenvironment can influence the 
differentiation of a valvular interstitial cell, perhaps attributes other than stiffness could 
also promote the reversion of fully differentiated myofibroblast-like VICs to fibroblast-
like VICs.  Changes in cytokines, such as TGF-, have been implicated in the 
differentiation process.  Since these cells were cultures in 10% FBS, the levels of TGF-  
are undefined, and may vary from lot to lot of serum.  Future experiments should address 
a possible role for growth factors in both the differentiation and the potential 
dedifferentiation of mitral VICs in vitro however, our results suggest that while 
substrate stiffness may play a role in VIC activation to the mitral VIC phenotype, simply 
changing the mechanical properties of the substrate is not sufficient to reverse this 
process. 
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 In the absence of dedifferentiation, scaffolds for valve replacements would be 
more difficult to seed and grow than if dedifferentiation were possible.  It may still be 
feasible to seed a scaffold with an individuals own cells, but they must be robust enough 
to overcome the high incidence of apoptosis and to repopulate the construct.  
Alternatively, cells could be expanded in vitro on substrates that encourage the 
dedifferentiated phenotype prior to seeding a scaffold.  Cellular communication and 
control over differentiation is not limited to the VICs themselves.  Nearby epithelial cells 
that directly interact with pumping blood and factors in the extracellular matrix likely 
provide signals to maintain or modify the state of the cell.  These factors should also be 
examined in an in vitro model to help elucidate further possible mechanisms of control 
that could be used in designing scaffolds.  Perhaps modulation of differentiation could be 
achieved by decorating scaffolds with growth factors or other signaling molecules. 
  Furthermore, it is known that dedifferentiation is not physiologically normal.  
Cancer is a pathological state where uncontrolled proliferation is often accompanied by 
dedifferentiation.  Reversion to a more primitive developmental state may result in cells 
no longer able perform the VICs function of matrix remodeling.  For the most part, the 
metabolic energy of a cell is put to use in driving the cell unidirectionally, with deviations 
resulting in malfunction of the cell.  Additional in vitro studies to examine the ability of 
cells on softer substrates to remodel. 
 Future studies with more diverse materials will help to develop better models for 
growing a functional valve from a patients own cells.  New culture conditions could 
allow laboratory grown mitral VICs to remain in a physiological state, similar to fresh 
isolates, with minimal further differentiation.  More studies into the mechanisms of 
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cellular communication are required to better understand the cells relationship with its 
environment.   
 26 
Citations 
 
Artificial valves hold hope for hearts Associated Press. 2 Apr. 2006: 3-6. InfoTrac. 
George C. Gordon Library, Worcester, MA. 11 Dec. 2006. 
 
Engler, A. J., M. A. Griffin, et al. (2004). "Myotubes differentiate optimally on substrates 
with tissue-like stiffness: pathological implications for soft or stiff 
microenvironments." J Cell Biol 166(6): 877-87. 
 
Focosi, Daniele. (2005) "Physiology of Adult Homo Sapiens -Heart." Date accessed: 
November 19, 2006. http://focosi.altervista.org/heart.html 
 
Hartzog, Kevin C.  The Cardiovascular System.  Date accessed:  November  21 
2006$4""*	*
"5,6!

"
"

* 
 
Hinds, Heather (2006).  Evaluating Terminal Differentiation of Porcine Valvular 
Interstitial Cells In Vitro. Masters Thesis:  Worcester Polytechnic Institute. pp 
42-43. 
 
Mulholland, D. L. and A. I. Gotlieb (1996). "Cell biology of valvular interstitial cells." 
Can J Cardiol 12(3): 231-6. 
 
Nagle, B.M. and OKeefe L.M. (1999). Closing in on mitral valve disease.   Nursing, 
29(4): 32cc1-7.  
 
Rabkin, E., M. Aikawa, et al. (2001). "Activated interstitial myofibroblasts express 
catabolic enzymes and mediate matrix remodeling in myxomatous heart valves." 
Circulation 104(21): 2525-32. 
 
Rabkin-Aikawa, E., M. Farber, et al. (2004). "Dynamic and reversible changes of 
interstitial cell phenotype during remodeling of cardiac valves." J Heart Valve Dis 
13(5): 841-7. 
 
Schoen, F. J. and R. J. Levy (1999). "Founder’s Award, 25th Annual Meeting of the 
Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. 
Tissue heart valves: current challenges and future research perspectives." J 
Biomed Mater Res 47(4): 439-65. 
 
Tomasek et al (2002).  Myofibroblasts and mechano-regulation of connective tissue 
remodeling.  Nat Rev Mol Cell Biol.  3(5):  349-63.   
 
Wang, Y. L. and R. J. Pelham, Jr. (1998). "Preparation of a flexible, porous 
polyacrylamide substrate for mechanical studies of cultured cells." Methods 
Enzymol 298: 489-96. 
 27 
 
Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and Neurotoxic Effects of 
Amyloid-Beta Protein: Reversal by Tachykinin Neuropeptides. Science 250:279-
282. 
